Tomoko Azuma

In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist

Satoshi Ozaki, Hiroshi Kawamoto, Yoshiki Itoh et al. · European Journal of Pharmacology · 2000 · 167 citations

Medicine, Medicinal Chemistry, Pharmacology +7

Pharmacological Characterization of a New, Orally Active and Potent Allosteric Metabotropic Glutamate Receptor 1 Antagonist, 4-[1-(2-Fluoropyridin-3-yl)-5-methyl-1 H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2 H)-carboxamide (FTIDC)

Gentaroh Suzuki, Toshifumi Kimura, Akio Satow et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 67 citations

Medicine, Medicinal Chemistry, Pharmacology +13

In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated [35S]GTPγS binding to mouse brain

Daisuke Ichikawa, Satoshi Ozaki, Tomoko Azuma et al. · Neuroreport · 2001 · 16 citations

Medicine, Neuroscience, Pharmacology +16

Successful Case of Periodontal Tissue Repair With Fibroblast Growth Factor‐2: Long‐Term Follow‐Up and Comparison to Enamel Matrix Derivative

Masami Ninomiya, Tomoko Azuma, Jun‐ichi Kido et al. · Clinical Advances in Periodontics · 2012 · 10 citations

Dentistry, Periodontics, Periodontology +16